.After antibody-drug conjugate (ADC) professional Seagen was actually sold to Pfizer in 2013 for an ...
.On the heels of a period 3 gain that fell short to make an impression on financiers, Ironwood Pharm...
.Do not quit Monte Rosa Therapies right now. The Boston-based biotech is actually enjoying after sig...
.Welcome to today's Chutes & Ladders, our roundup of notable leadership hirings, firings and reti...
.Celebrating his business's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...
.AbbVie has returned to the source of its antipsychotic goliath Vraylar seeking an additional smash ...
.GenSight Biologics is weeks off of running out of loan. Once more. The biotech just has adequate mo...
.Monopar Rehabs is recouping a medicine from the scrap heap of AstraZeneca's rare illness pipeline. ...
.Along with brand-new information out on Arcus Biosciences' experimental HIF-2a prevention, one grou...
.After creating a genetics therapy partnership with Dyno Rehabs in 2020, Roche is back for more.In a...